Skip to main content
TipRanks
Go Ultimate75% OFF

Marker Therapeutics (MRKR) Q3 2019 Earnings Report

610 Followers

MRKR Q3 2019 EPS Results

Actual EPS
-$1.20
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$3.20

MRKR Q3 2019 Revenue Results

Actual Revenue
$0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2019
Date
11/12/2019
Time
After Close
Conference Call
Tuesday, November 12, 2019
MRKR Upcoming Earnings

Marker Therapeutics's next earnings date is estimated for March 24, 2027, based on past reporting schedules.

Q3 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

MRKR Earnings History

MRKR earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 24, 20272026 (Q4)-0.20--0.1――
Nov 16, 20262026 (Q3)-0.12-0.10-0.1216.67% (+0.02)
Aug 19, 20262026 (Q2)-0.13-0.09-0.2564.00% (+0.16)
May 20, 20262026 (Q1)-0.16-0.16-0.460.00% (+0.24)
Mar 18, 20262025 (Q4)-0.19-0.10-0.4175.61% (+0.31)
Nov 14, 20252025 (Q3)-0.36-0.12-0.2653.85% (+0.14)
Aug 14, 20252025 (Q2)-0.30-0.25-0.250.00% (+0.00)
May 15, 20252025 (Q1)―--0.27―
Mar 31, 20252024 (Q4)-0.53-0.40-0.27-48.15% (-0.13)
Nov 14, 20242024 (Q3)-0.39-0.26-0.3423.53% (+0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed